Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: A systematic review

Transfusion Medicine Reviews

Volumn 27, Issue 4, 2013, Pages 221-234

  Lin, David M ^a   Lin, Estelle S ^b   Tran, Minh Ha ^c,d  

^a LIN SHIN HOSPITAL   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Transfusion Medicine Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ERYTHROPOIETIN; FERROPORTIN; FERROUS GLUCONATE; FERROUS SULFATE; HEMOGLOBIN; IRON; IRON SACCHARATE; PLACEBO;

ANAPHYLAXIS; BLOOD CONSERVATION; BLOOD DONOR; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CINAHL; COCHRANE LIBRARY; COLORECTAL CANCER; CONSTIPATION; CORONARY ARTERY BYPASS GRAFT; DELIVERY; DIET SUPPLEMENTATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ERYTHROCYTE TRANSFUSION; HEAD AND NECK CANCER; HEMOGLOBIN BLOOD LEVEL; HIP FRACTURE; HUMAN; HYPOTENSION; HYSTERECTOMY; INFECTION; INTESTINE CELL; INTRAOPERATIVE PERIOD; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON THERAPY; LOW DRUG DOSE; MACROPHAGE; MEDLINE; MENORRHAGIA; METALLIC TASTE; MONOTHERAPY; MORTALITY; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; SINGLE DRUG DOSE; SPINE SURGERY; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; UTERUS MYOMA;

CLINICAL TRIALS AS TOPIC; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MULTICENTER STUDIES AS TOPIC; PATIENT SAFETY; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SURGICAL PROCEDURES, OPERATIVE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84886751168     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2013.09.001     Document Type: Review

References (62)

1. Hill G.E., Frawley W.H., Griffith K.E., Forestner J.E., Minei J.P. Allogeneic blood transfusion increases the risk of post-operative bacterial infection: a meta-analysis. J Trauma 2003, 54:908-914.
2. Carson J.L., Grossman B.J., Kleinman S., Tinmouth A.T., Marques M.B., Fung M.K., et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012, 157:49-58.
3. Lin D.M., Murphy L.S., Tran M.H. Use of Prothrombin Complex Concentrates and Fibrinogen Concentrates in the Perioperative Setting: A Systematic Review. Transfus Med Review 2013, 27:91-104.
4. PROCRIT® (Epoeitin alfa) [prescribing information]. Raritan, NJ: Ortho Biotech Products LP; 2013.
5. Goldberg M.A., McCutchen J.W., Jove M., Di Cesare P., Friedman R.J., Poss R., et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996, 25:544-552.
6. Cheung W.K., Goon B.L., Guilfoyle M.C., Wacholtz M.C. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. Clin Pharmacol Ther 1998, 64:412-423.
7. Andrews N.C. Disorders of iron metabolism. N Engl J Med 1999, 341:1986-1995.
8. Goodnough L.T. Iron deficiency syndromes and iron-restricted erythropoiesis. Transfusion 2012, 52:1584-1592.
9. Goodnough L.T., Shander A., Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003, 43:668-676.
10. Wysowski D.K., Swartz L., Borders-Hemphill B.V., Goulding M.R., Dormitzer C. Use of parenteral iron products and serious anaphylactic-type reactions. Am J Hematol 2010, 85:650-654.
11. Bastani B., Rahman S., Gellens M. Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran. ASAIO J 2002, 48:404-406.
12. Faich G., Strobos J. Sodium ferric gluconate complex in sucrose: safer IV iron therapy than iron dextrans. Am J Kidney Dis 1999, 33:464-470.
13. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 10:1011-1023.
14. Auerbach M., Goodnough L.T., Picard D., Maniatis A. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion 2008, 48:988-1000.
15. Beris P., Munoz M., Garcia-Erce J.A., Thomas D., Maniatis A., Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008, 100:599-604.
16. Munoz M., Garcia-Erce J.A., Villar I., Thomas D. Blood conservation strategies in major orthopaedic surgery: efficacy, safety, and European regulations. Vox Sang 2009, 96:1-13.
17. Munoz M., Breymann C., Garcia-Erce J.A., Gomez-Ramirez S., Comin J., Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008, 94:172-183.
18. van Iperen C.E., Kraainjenhagen R.J., Biesma D.H., Beguin Y., Marx J.J., van de Wiel A. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998, 85:41-45.
19. Ashby D.R., Gale D.P., Bushbridge M., Murphy K.G., Duncan N.D., Cairns T.D., et al. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 2010, 95:505-508.
20. Biesma D.H., van de Wiel A., Beguin Y., Kraaijenhagen J., Marx J.J. Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995, 25:383-389.
21. Goodnough L.T., Skikne B., Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000, 96:823-833.
22. de Andrade J.R., Frei D., Guilfoyle M. Integrated analysis of thrombotic/vascular event occurrence in epoetin alfa-treated patients undergoing major, elective orthopedic surgery. Orthopedics 1999, 22:s113-s118.
23. Hirsh J., Guyatt G., Albers G.W., Harrington R., Schunemann H.J. Antithrombotic and thrombolytic therapy 8th Edition: ACCP guidelines. Chest 2008, 133:71S-105S.
24. Serrano-Trenas J.A., Ugalde P.F., Cabello L.M., Chofles L.C., Lazaro P.S., Benitez P.C. Role of perioperative IV iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion 2011, 51:97-104.
25. Cuenca J., Garcia-Erce J.A., Munoz M., Izuel M., Martinez A.A., Herrera A. Patients with pertrochanteric hip fracture may benefit from preoperative IV iron therapy: a pilot study. Transfusion 2004, 44:1447-1452.
26. Cuenca J., Garcia-Erce J.A., Martinez A.A., Solano V.M., Molina J., Munoz M. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 2005, 125:342-347.
27. Munoz M., Naveira E., Seara J., Palmer J.H., Cuenca J., Garcia-Erce J.A. Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. Transfus Med 2006, 16:137-142.
28. Bhandal N., Russell R. IV versus oral iron therapy for postpartum anaemia. BJOG 2006, 113:1248-1252.
29. Kim Y.H., Chung H.H., Kang S.B., Kim S.C., Kim Y.T. Safety and usefulness of IV iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. Acta Haematol 2009, 121:37-41.
30. Diez-Lobo A.I., Fisac-Martin M.P., Bermejo-Aycar I., Munoz M. Preoperative IV iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy. Transfusion Alter Transfusion Med 2007, 9:114-119.
31. Armand-Ugon R., Cheong T., Matapandewu G., Rojo-Sanchis A., Bisbe E., Munoz M. Efficacy of IV iron for treating postpartum anemia in low-resource African countries: a pilot study in Malawi. J Womens Health 2011, 20:123-127.
32. Edwards T.J., Noble E.J., Durran A., Mellor N., Hosie K.B. Randomized clinical trial of preoperative IV iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. Br J Surg 2009, 96:1122-1128.
33. Titos-Arcos J.C., Soria-Aledo V., Carrillo-Alcaraz A., Ventura-Lopez M., Palacios-Munoz S., Pellicer-Franco E. Is IV Iron Useful for Reducing Transfusions in Surgically Treated Colorectal Cancer Patients?. World J Surg 2012, 36:1893-1897.
34. Deutsch A., Spaulding J., Marcus R.E. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty. J Arthroplasty 2006, 21:628-635.
35. Feagan B.G., Wong C.J., Kirkley A., Johnston D.W., Smith F.C., Whitsitt P., et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized controlled trial. Ann Intern Med 2000, 133:845-854.
36. Stowell C.P., Chandler H., Jove M., Guilfoyle M., Wacholtz M.C. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedic 1999, 22:s105-s112.
37. Stowell C.P., Jones S.C., Enny C., Langholff W., Leitz G. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine 2009, 34:2479-2485.
38. Weber E.W., Slappendel R., Hemon Y., Mahler S., Dalen T., Rouwet E. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005, 22:249-257.
39. Cushner F.D., Locker J.R., Hanssen A.D., Jacofsky D.J., Scott W.N., Scuderi G.R., et al. Use of recombinant human erythropoietin in two-stage total knee arthroplasty for infection. Clin Orthop Relat Res 2001, 392:116-123.
40. Laffosse J.M., Minville V., Chiron P., Colombani A., Gris C., Pourrut J.C. Preoperative use of epoietin beta in total hip replacement: a prospective study. Arch Orthop Trauma Surg 2010, 130:41-45.
41. Cushner F.D., Lee G.C., Scuderi G.R., Arsht S.J., Scott W.N. Blood loss management in high-risk patients undergoing total knee arthroplasty: a comparison of two techniques. J Knee Surg 2006, 19:249-253.
42. Kourtzis N., Pafilas D., Kasimatis G. Blood saving protocol in elective total knee arthroplasty. Am J Surg 2004, 187:261-267.
43. Sesti F., Ticconi C., Bonifacio S., Piccione E. Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery. Gynecol Obstet Invest 2002, 54:1-5.
44. Dousias V., Paraskevaidis E., Dalkalitsis N., Tsanadis G., Navrozoglou I., Lolis D. Recombinant human erythropoietin in mildly anemic women before total hysterectomy. Clin Exp Obstet Gynecol 2003, 30:235-238.
45. Larson B., Katarina B., Clyne N., Nordstrom L. Preoperative treatment of anemic women with epoetin beta. Acta Obstet Gynecol Scand 2001, 80:559-562.
46. Christodoulakis M., Tsiftsis D.D. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study. Ann Surg Oncol 2005, 12:718-725.
47. Qvist N., Boesby S., Wolff B., Hansen C.P. Recombinant human erythropoietin and Hb concentration at operation and during the postoperative period: Reduced need for blood transfusions in patients undergoing colorectal surgery - prospective double-blind placebo-controlled study. World J Surg 1999, 23:30-35.
48. Scott S.N., Boeve T.J., McCulloch T.M., Fitzpatrick K.A., Karnell L.H. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope 2002, 112:1221-1229.
49. Nieder A.M., Rosenblum N., Lepor H. Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. Urology 2001, 57:737-741.
50. Weltert L., D'Alessandro S., Nardella S., Girola F., Bellisario A., Maselli D., et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: A randomized blind controlled study. J Thorac Cardiovasc Surg 2010, 139:621-627.
51. Yazicioglu L., Eryilmaz S., Sirlak M., Bahadir M., Aral A., Tasoz R., et al. Recombinant human erythropoietin administration in cardiac surgery. J Thorac Cardiovasc Surg 2001, 122:741-745.
52. Kateros K., Sakellariou V.I., Sofianos I.P., Papagelopoulos P.J. Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture. J Crit Care 2010, 25:348-353.
53. Na H.S., Shin S.Y., Hwang J.Y., Jeon Y.T., Kim C.S., Do S.H. Effects of IV iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011, 51:118-124.
54. Olijhoek G., Megens J.G., Musto P., Nogarin L., Gassmann-Mayer C., Vercammen E., et al. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion 2001, 41:957-963.
55. Garcia-Erce J.A., Cuenca J., Munoz M., Izuel M., Martinez A.A., Herrera A., et al. Perioperative stimulation of erythropoiesis with IV iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005, 88:235-243.
56. Gonzalez-Porras J.R., Colado E., Conde M.P., Lopez T., Nieto M.J., Corral M. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty. Transfus Med 2009, 19:35-42.
57. Garcia-Erce J.A., Cuenca J., Haman-Alcober S., Martinez A.A., Herrera A., Munoz M. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sang 2009, 97:260-267.
58. Braga M., Gianotti L., Gentilini O., Vignali A., Corizia L., Di Carlo V. Erythropoiesis after therapy with recombinant human erythropoietin: a dose-response study in anemic cancer surgery patients. Vox Sang 1999, 76:38-42.
59. Kettelhack C., Hones C., Messinger D., Schlag P.M. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients underoing right hemicolectomy for carcinoma. Br J Surg 1998, 85:63-67.
60. Karkouti K., McCluskey S.A., Ghannam M., Salpeter M.J., Quirt I., Yau T.M. IV iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth 2006, 53:11-19.
61. Madi-Jebara S.N., Sleilaty G.S., Achouh P.E., Yazigi A.G., Haddad F.A., Hayek G.M., et al. Postoperative IV iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004, 18:59-63.
62. Yoo Y.C., Shim J.K., Kim J.C., Jo Y.Y., Lee J.H., Kwak Y.L. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011, 15:929-937.